Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    December 2017
  1. SHEPHERD L, Ryom L, Law M, Hatleberg CI, et al
    Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    J Natl Cancer Inst. 2017 Dec 18. pii: 4757458. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  2. MORTON LM, Sampson JN, Armstrong GT, Chen TH, et al
    Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    September 2017
  3. SANCHEZ-MARTIN D, Uldrick TS, Kwak H, Ohnuki H, et al
    Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    June 2017
  4. THOMAS A, Link BK, Altekruse S, Romitti PA, et al
    Primary Breast Lymphoma in the United States: 1975-2013.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  5. BLOMBERY P, Prince HM, Seymour JF
    Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of Lymphoma.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    April 2017
  6. DIEFENBACH CS, Connors JM, Friedberg JW, Leonard JP, et al
    Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    March 2017
  7. MADDOCKS K, Barr PM, Cheson BD, Little RF, et al
    Recommendations for Clinical Trial Development in Follicular Lymphoma.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    February 2017
  8. CASULO C, O'Connor O, Shustov A, Fanale M, et al
    T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    January 2017
  9. SPURGEON SE, Till BG, Martin P, Goy AH, et al
    Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    December 2016
  10. NOWAKOWSKI GS, Blum KA, Kahl BS, Friedberg JW, et al
    Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  11. RIMSZA L, Fedoriw Y, Staudt LM, Melnick A, et al
    General Biomarker Recommendations for Lymphoma.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    November 2016
  12. XIAO DY, Luo S, O'Brian K, Sanfilippo KM, et al
    Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    July 2016
  13. HODGSON DC, Cotton C, Crystal P, Nathan PC, et al
    Impact of Early Breast Cancer Screening on Mortality Among Young Survivors of Childhood Hodgkin's Lymphoma.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    February 2016
  14. TENG CJ, Hu YW, Chen SC, Yeh CM, et al
    Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    December 2015
  15. SAMPSON JN, Wheeler WA, Yeager M, Panagiotou O, et al
    Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.
    J Natl Cancer Inst. 2015;107:djv279.
    PubMed     Text format     Abstract available


    October 2015
  16. SINHA G
    Banked Donor T-Cells Treat Virus-Related B Cell Disorder when Rituximab Fails.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: